Cellular cofactors for amyloid β-peptide-induced cell stress: Moving from cell culture to in vivo

American Journal of Pathology

Volumn 155, Issue 5, 1999, Pages 1403-1411

  Shi Du Yan, ^a   Roher, A ^a   Schmidt, A M ^a   Stern, D M ^a  

^a The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; AMYLOID BETA PROTEIN; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; COMPLEMENT ACTIVATION; HUMAN; NERVE FUNCTION; NOTE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION;

EID: 0032706735     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9440(10)65452-1     Document Type: Note

References (118)

1. J Hardy Amyloid, the presenilins, and Alzheimer's disease Trends Neurosci 29556 1997 28570 28998
2. M Citron D Westaway W Xia G Carlson T Diehl G Levesque K Johnson-Wood M Lee P Seubert A Davis D Kholodenko R Motter R Sherrington B Perry H Yao R Strome I Lieberburg J Rommens S Kim D Schenk P Fraser P St.George-Hyslop D Selkoe Mutant presenilins of Alzheimer's disease increase production of 42-residue Aβ in both transfected cells and transgenic mice Nat Med 3 1997 67 72
3. P St.George-Hyslop Role of genetics in tests of genotype, status, and disease progression in early-onset Alzheimer's disease Neurobiol Aging 19 1998 133 137
4. D Selkoe Cell biology of βAPP and the mechanism of Alzheimer's disease Annu Rev Cell Biol 10 1999 373 403
5. A Liao R Nitsch S Greenberg U Finckh D Blacker M Albert G Rebeck T Gomez-Isla A Clatworthy G Binetti C Hock T Mueller-Thomsen U Mann K Zuchowski U Beisiegel H Staehelin J Growdon R Tanzi B Hyman Genetic association of an α-2-macroglobulin (Val1000Ile) polymorphism and Alzheimer's disease Hum Mol Genet 12 1998 1953 1956
6. D Blacker M Wilcox N Laird L Rodes S Horvath R Go R Perry B Watson S Bassett M McInnis M Albert B Hyman R Tanzi α2-Macroglobulin is genetically associated with AD Nat Genet 19 1998 357 360
7. D Goldgaber A Schwarzman R Bhasin L Gregori D Schmechel AM Saunders AD Roses WJ Strittmatter Sequestration of Aβ Ann NY Acad Sci 695 1993 139 143
8. A Roses Apolipoprotein E and Alzheimer's disease: the tip of the susceptibility iceberg Ann NY Acad Sci 855 1998 738 743
9. M Nishimura G Yu G Levesque D Zhang L Ruel F Chen P Milman E Holmes Y Liang T Kawarai E Jo A Supala E Rogaeva D Xu J Levesque Q Bi M Duthie R Rozmahel K Mattila L Lannfelt D Westaway H Mount J Woodgett P St. George-Hyslop Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of β-catenin, a component of the presenilin protein complex Nat Med 2 1999 164 169
10. D Cook M Forman J Sung S Leight T Iwatsubo V Lee R Doms Aβ (1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells Nat Med 3 1997 1021 1023
11. T Hartmann S Bieger B Bruhl P Tienari N Ida D Allsop G Roberts C Masters C Cotti K Unsicher K Beyreuther Distinct sites of intracellular production for Aβ 40/42 amyloid peptides Nat Med 3 1997 1016 1020
12. P Tienari N Ida E Ikonen M Simons A Weidemann G Multhaup C Masters C Dotti K Beyreuther Intracellular and secreted Alzheimer β-peptide species are generated by distinct mechanisms in cultured hippocampal neurons Proc Natl Acad Sci USA 94 1997 4125 4130
13. C Wild-Bode T Yamazaki A Capeil U Leimer H Steiner Y Ihara C Haass Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42 J Biol Chem 272 1997 16085 16088
14. W Xia J Zhang B Ostaszweski W Kimberly P Seubert E Koo J Shen D Selkoe Presenilin 1 regulates the processing of APP C-terminal fragments, and the generation of Aβ in ER and Golgi Biochemistry 37 1998 16465 16471
15. DJ Selkoe Translating cell biology into therapeutic advances in Alzheimer's disease Nature 399 suppl 1999 A23 A31
16. C Esmon Cell-mediated events that control blood coagulation and vascular injury Annu Rev Cell Biol 9 1993 1 26
17. E Gahtan J Overmier Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequelae Neurosci Biobehav Rev 23 1999 615 633
18. E McGeer P McGeer Role of the immune systme in neurodegenerative disorders Mov Disord 12 1997 855 858
19. K Yasojima C Schwab E McGeer P McGeer Up-regulated production and activation of the complement system in Alzheimer's disease brain Am J Pathol 154 1999 927 936
20. J Daly G Kotwal Pro-inflammatory complement activation by the Aβ of Alzheimer's disease is biologically significant and can be blocked by vaccinia virus complement control protein Neurobiol Aging 19 1998 619 627
21. K Hensley J Carney M Mattson M Aksenova M Harris J Wu R Floyd D Butterfield A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease Proc Natl Acad Sci USA 91 1994 3270 3274
22. M Mattson Y Goodman Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium Brain Res 676 1995 219 224
23. R Mark E Blanc M Mattson Aβ and oxidative cellular injury in Alzheimer's disease Mol Neurobiol 12 1996 915 924
24. M Mattson Free radicals and disruption of neuronal ion homeostasis in Alzheimer's disease: a role for amyloid β-peptide? Neurobiol Aging 16 1995 679 682
25. K Boland M Behrens D Choi K Manias D Perlmutter The serpin-enzyme complex receptor recognizes soluble, nontoxic Aβ but not aggregated, cytotoxic Aβ J Biol Chem 271 1996 18032 18044
26. K Boland K Manias D Perlmutter Specificity in recognition of Aβ by the serpin-enzyme complex receptor in hepatoma cells and neuronal cells J Biol Chem 270 1995 28022 28028
27. M Matter Z Zhang C Nordstadt E Ruoslahti The α-5 β-1 integrin receptor binds the Alzheimer disease amyloid-β protein and mediates its internalization Keystone Symp Proc X5 1998 101 (abstr.)
28. D Watson A Lander D Selkoe Heparin-binding properties of the amyloidogenic peptides Aβ and amylin J Biol Chem 272 1997 31617 31624
29. D Giulian L Haverkamp J Yu W Karshin D Tom J Li A Kazanskaia J Kirkpatrick A Roher The HHQK domain of Aβ provides a structural basis for the immunopathology of Alzheimer's disease J Biol Chem 273 1998 29719 29726
30. L Buee W Ding A Delacourte H Fillit Binding of secreted human neuroblastoma proteoglycans to Alzheimer's amyloid A4 peptide Brain Res 601 1993 154 163
31. L Buee W Ding J Anderson S Narindrasorasak R Kisilevsky N Boyle N Robakis A Delacourte B Greenberg H Fillit Binding of vascular heparan sulfate proteoglycan to Alzheimer's APP is mediated in part by the N-terminal region of A4 peptide Brain Res 627 1993 199 204
32. L Shaffer M Dority R Gupta-Bansal R Frederickson S Younkin K Brunden Aβ removal by neuroglial cells in culture Neurobiol Aging 16 1995 737 745
33. A Snow M Kinsella E Parks R Sekiguchi J Miller K Kimata T Wight Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to Aβ Arch Biochem Biophys 320 1995 84 95
34. A Snow R Sekiguchi D Nochlin P Fraser K Kimata A Mizutani M Arai W Schreier D Morgan An important role for heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar Aβ in rat brain Neuron 12 1994 219 234
35. G Castillo C Ngo J Cummings T Wight A Snow Perlecan binds to the β-amyloid proteins (A-β) of Alzheimer's disease, accelerates Aβ fibril formation, and maintains Aβ fibril stability J Neurochem 69 1997 2452 2465
36. S Narindrasorasak D Lowery P Gonzalez-DeWitt R Poorman B Greenberg R Kisilevsky High affinity interactions between the βAPP and the basement membrane form of heparan sulfate proteoglycan J Biol Chem 266 1991 12878 12883
37. K Brunden N Richert-Cook N Chaturvedi R Frederickson pH-dependent binding of synethetic Aβ to glycosaminoglycans J Neurochem 61 1993 2147 2154
38. T Hardingham A Fosang Proteoglycans: many forms and many functions FASEB J 6 1992 861 870
39. L Li M Safran D Aviezer P Bohlen A Seddon A Yayon Diminished heparin binding of bFGF mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesis Biochemistry 33 1994 10999 11007
40. D Aviezer D Hecht M Safran M Eisinger G David A Yayon Perlecan, basal lamina proteoglycan, promotes bFGF-receptor binding, mitogenesis, and angiogenesis Cell 79 1994 1005 1013
41. M Kan X Wu F Wang W McKeehan Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase J Biol Chem 274 1999 15947 15952
42. I Vlodavsky H Miao R Atzmon E Levi J Zimmermann R Bar-Shavit T Peretz S Ben-Sasson Control of cell proliferation by heparan sulfate and heparin-binding growth factors Thromb Haemost 74 1995 534 540
43. M Narita D Holtzman A Schwartz G Bu α2-Macroglobulin complexes with, and mediates the endocytosis of Aβ via cell surface LRP J Neurochem 69 1997 1904 1911
44. F LaFerla J Troncoso D Strickland C Kawas G Jay Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Aβ stabilization J Clin Invest 100 1997 310 320
45. Z Ji W Brecht R Miranda M Hussain T Innerarity R Mahley Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells J Biol Chem 268 1993 10160 10167
46. C Lendon C Talbot N Craddock S Han M Wragg J Morris A Goate Genetic association studies between dementia of the Alzheimer's type and three receptors for apoE in a Caucasian population Neurosci Lett 222 1997 187 190
47. J El Khoury S Hickman C Thomas L Cao S Silverstein J Loike Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils Nature 382 1996 716 719
48. DM Paresce RN Ghosh FR Maxfield Microglial cells internalize aggregates of the Alzheimer's disease Aβ via a scavenger receptor Neuron 17 1996 553 565
49. M Krieger J Herz Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein Annu Rev Biochem 63 1994 601 637
50. A Pearson A Rich M Krieger Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices J Biol Chem 268 1993 3546 3554
51. R Christie M Freeman B Hyman Expression of the macrophage scavenger receptor, a multifunctional lipoprotein receptor, in microglia associated with senile plaques in Alzheimer's disease Am J Pathol 148 1996 399 403
52. P Gough D Greaves H Suzuki T Hakkinen M Hiltunen M Turunen S Herttuala T Kodama S Gordon Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions Arterioscler Thromb Vasc Biol 19 1999 461 471
53. R Hampton D Golenbock M Penman M Krieger C Raetz Recognition and plasma clearance of endotoxin by scavenger receptors Nature 352 1991 342 344
54. H Suzuki Y Kurihara M Takeya N Kamada M Kataoka K Jishage O Ueda H Sakaguchi T Higashi T Suzuki Y Takashima Y Kawabe O Cynshi Y Wada M Honda H Kurihara H Aburatani T Doi A Matsumoto S Azuma T Moda Y Toyoda H Itakura Y Yaxaki T Kodama A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection Nature 386 1997 292 296
55. M deWinther M Gijbels K vanDijk P vanGorp H Suzuki T Kodama R Frants L Havekes M Hofker Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice Atherosclerosis 144 1999 315 321
56. F Huang M Buttini T Wyss-Coray L McConlogue T Kodama R Pitas L Mucke Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid precursor proteins Am J Pathol 155 1999 1741 1747
57. M Mullan F Crawford K Azelman H Houlden L Lillius B Winblad L Lannfelt A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid Nat Genet 1 1992 345 347
58. J Murrell M Farlow B Ghetti M Benson A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease Science 254 1991 97 99
59. A Hsia E Masliah L McConlogue G-Q Yu G Tatsuno K Hu D Kholodenko R Malenka R Nicoll L Mucke Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models Proc Natl Acad Sci USA 96 1999 3228 3233
60. T Wyss-Coray E Masliah M Mallory L McConlogue K Johnson-Wood C Lin L Mucke Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease Nature 389 1997 603 606
61. C Sze J Troncoso C Kowas P Mouton D Price J Martin Loss of presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease J Neuropathol Exp Neurol 56 1997 933 944
62. R Terry E Masliah D Salmon N Butters R DeTeresa R Hill L Hansen R Katzman Physical basis of cognitive alterations in Alzheimer disease: synapse loss is the major correlate of cognitive impairment Ann Neurol 30 1991 572 580
63. S Zhan K Beyreuther H Schmitt Quantitative assessment of synaptophysin immunoreactivity of the cortical neuropil in various neurodegenerative diseases with dementia Dementia 4 1993 66 74
64. D Games D Adams R Alessandrini R Barbour P Berthelette C Blackwell T Carr J Clemens T Donaldson F Gillespie T Guido S Hagopian K Johnson-Wood K Khan M Lee P Leibowitz I Lieberburg S Little E Masliah L McConlogue M Montoya-Zavala L Mucke L Pganini E Penniman M Power D Schenk P Seubert B Snyder F Soriano H Tan J Vitale S Wadsworth B Wolozin J Zhao Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein Nature 373 1995 523 527
65. D Games K Khan F Soriano D Davis K Bryant I Liebergburg Lack of Alzheimer pathology after β-amyloid protein injections in the brain Neurobiol Aging 13 1992 569 576
66. D Borchelt G Thinakaran C Eckman M Lee F Davenport T Ratovitsky C-M Prada G Kim S Seekins D Yager H Slunt R Wang M Seeger A Levey S Gandy N Copeland N Jenkins D Price S Younkin S Sisodia Familial Alzheimer's disease-linked presenilin 1 variants elevate amyloid-β 1–42/1–40 ratio in vitro and in vivo Neuron 17 1996 1005 1013
67. D Borchelt T Ratovitski J vanLare M Lee V Gonzales N Jenkins N Copeland D Price S Sisodia Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins Neuron 19 1997 939 945
68. I Hsiao P Chapman S Nilsen C Eckman Y Harigaya S Younkin F Yang G Cole Correlative memory deficits, amyloid β-peptide elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102
69. P Chapman G White W Jones D Cooper-Blacketer V Marshall M Irizarry L Younkin M Good T Bliss B Hyman S Younkin K Hsiao Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice Nat Neurosci 2 1999 271 276
70. M Calhoun K-H Wiederhod D Abramowski A Phinney A Probst C Sturchler-Pierrat M Staufenbiel B Sommer M Jucker Neuron loss in APP transgenic mice Nature 395 1998 755 756
71. M Yaar S Zhai P Pilch S Doyle P Eisenhauer R Fine B Gilchrest Binding of β-amyloid to the p75 neurotrophin receptor induces apoptosis J Clin Invest 100 1997 2333 2340
72. T Kislinger C Fu W Qu S-D Yan M Hofmann S-F Yan M Pischetstrieder D Stern A-M Schmidt Nɛ-(carboxymethyl)-lysine adducts of proteins are ligands for RAGE that activate cell signalling pathways, and modulate gene expression J Biol Chem 274 1999 31740 31749
73. AM Schmidt M Vianna M Gerlach J Brett J Ryan J Kao C Esposito H Hegarty W Hurley M Clauss F Wang YC Pan TC Tsang DM Stern Isolation and characterization of binding proteins for AGEs from lung tissue which are present on the endothelial cell surface J Biol Chem 267 1992 14987 14997
74. M Neeper AM Schmidt J Brett SD Yan F Wang YC Pan K Elliston DM Stern A Shaw Cloning and expression of RAGE: a cell surface receptor for AGEs J Biol Chem 267 1992 14998 15004
75. O Hori J Brett M Nagashima D Nitecki J Morser DM Stern AM Schmidt RAGE is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system J Biol Chem 270 1995 25752 25761
76. S-D Yan X Chen M Chen H Zhu A Roher T Slattery L Zhao M Nagashima J Morser A Migheli P Nawroth DM Stern A-M Schmidt RAGE and Aβ neurotoxicity in Alzheimer's disease Nature 382 1996 685 691
77. A-M Schmidt S-D Yan J-L Wautier DM Stern Activation of RAGE: a mechanism for chronic dysfunction in diabetic vasculopathy and atherosclerosis Circ Res 84 1999 489 497
78. M Hofmann S Drury F Caifeng W Qu Y Lu C Avila N Kambhan T Slattery J McClary M Nagashima J Morser D Stern A-M Schmidt RAGE mediates a novel proinflammatory axis: the cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901
79. VR Racaniello Early events in poliovirus infection: virus-receptor interactions Proc Natl Acad Sci USA 93 1996 11378 11381
80. J Brett A-M Schmidt Y-S Zou S-D Yan E Weidman DJ Pinsky M Neeper M Przysiecki A Shaw A Migheli DM Stern Tissue distribution of the RAGE: expression in smooth muscle, cardiac myocytes, and neural tissue in addition to vasculature Am J Pathol 143 1993 1699 1712
81. MS Brown JL Goldstein A receptor-mediated pathway for cholesterol homeostasis Science 232 1986 34 47
82. J Li A-M Schmidt Characterization and functional analysis of the promoter of RAGE J Biol Chem 272 1997 16498 16506
83. J Mackic M Stins J McComb M Calero J Ghiso K Kin S-D Yan D Stern A-M Schmidt B Frangione B Zlokovic Human blood-brain barrier receptors for Aβ 1–40 J Clin Invest 102 1998 734 743
84. H Lander J Tauras J Ogiste R Moss AM Schmidt Activation of RAGE triggers a MAP kinase pathway regulated by oxidant stress J Biol Chem 272 1997 17810 17814
85. S-D Yan H Zhu J Fu S-F Yan A Roher WW Tourtellotte T Rajavashisth X Chen GC Godman D Stern AM Schmidt Aβ-RAGE interaction elicits neuronal expression of M-CSF: a proinflammatory pathway in Alzheimer disease Proc Natl Acad Sci USA 94 1997 5296 5301
86. P Fixe V Praloran M-CSF: haematopoietic growth factor or inflammatory cytokine? Cytokine 10 1998 32 37
87. J Hamilton CSF-1 signal transduction J Leukoc Biol 62 1997 145 155
88. H Akiyama T Nishimura H Kondo K Ikeda Y Hayashi P McGeer Expression of the receptor for M-CSF by brain microglia and its upregulation in brains of patients with Alzheimer's disease and amyotrophic lateral sclerosis Brain Res 639 1994 171 174
89. D Hume X Yue I Ross P Favot A Lichanska M Ostrowski Regulation of CSF-1 receptor expression Mol Reprod Dev 46 1997 46 52
90. M Pappolla Y-J Chyan R Omar K Hsiao G Perry M Smith P Bozner Evidence of oxidative stress and in vivo neurotoxicity of Aβ in a transgenic mouse model of Alzheimer's disease Am J Pathol 152 1998 871 877
91. Y Liu R Dargusch D Schubert Beta amyloid toxicity does not require RAGE protein Biochem Biophys Res Commun 237 1997 37 40
92. J Sheng R Mrak C Rovnaghi E Kozlowska L Van Eldik W Griffin Human brain S100β and S100β mRNA expression increases with age: pathogenic implications for Alzheimer's disease Neurobiol Aging 17 1996 359 363
93. SD Yan J Fu C Soto X Chen H Zhu F Al-Mohanna K Collison A Zhu E Stern T Saido M Tohyama S Ogawa A Roher D Stern An intracellular protein that binds Aβ and mediates neurotoxicity in Alzheimer's disease Nature 389 1997 689 695
94. S-D Yan Y Shi A Zhu J Fu H Zhu Y Zhu L Gibson K Collison F Al-Mohanna S Ogawa A Roher S Clarke DM Stern Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in amyloid β-peptide-induced cytotoxicity J Biol Chem 274 1999 2145 2156
95. A Kobayashi L Jiang T Hashimoto Two mitochondrial 3-hydroxyacyl-CoA dehydrogenases in bovine liver J Biochem 119 1996 775 782
96. S Furuta A Kobayashi S Miyazawa T Hashimoto Cloning and expression of cDNA for a newly identified isozyme of bovine liver 3-hydroxyacyl-CoA dehydrogenase and its import into mitochondria Biochim Biophys Acta 1350 1997 317 324
97. X-Y He H Schulz S-Y Yang A human brain L-3-hydroxyacyl-coenzyme A dehydrogenase is identical to amyloid β-peptide-binding protein involved in Alzheimer's disease J Biol Chem 273 1998 10741 10746
98. X-Y He P Mehta H Schulz S-Y Yang Human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase is a single-domain multifunctional enzyme J Biol Chem 274 1999 15014 15019
99. M Aridor W Balch Integration of endoplasmic reticulum signaling in health and disease Nat Med 5 1999 745 751
100. M-X Tang D Jacobs Y Stern K Marder P Schofield B Gurland H Andrews R Mayeux Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease Lancet 348 1994 429 432
101. C Behl M Widman T Trapp F Holsboer 17β-Estradiol protects neurons from oxidative stress-induced cell death in vitro Biochem Biophys Res Commun 216 1995 473 482
102. J Keller A Germeyer J Begley M Mattson 17β-Estradiol attenuates oxidative impairment of synaptic Na/K-ATPase activity, glucose transport, and glutamate transport induced by Aβ and iron J Neurosci 15 1997 522 530
103. R Mark M Lovell W Markesbery K Uchida M Mattson A role for 4-HNE in disruption of ion homeostasis and neuronal death induced by Aβ J Neurochem 68 1997 255 264
104. A Roher M Chaney Y Kuo S Webster W Stine L Haverkamp A Woods R Cotter J Tuohy G Krafft B Bonnell M Emmerling Morphology and toxicity of Aβ(1–42) dimer dervied from neuritic and vascular amyloid deposits of Alzheimer's disease J Biol Chem 271 1996 20631 20635
105. J Kirkpatrick G Murdoch M Ball A Roher Water soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains J Biol Chem 271 1996 4077 4081
106. M Lambert A Barlow B Chrom C Edwards R Freed M Liosatos T Morgan I Rozovsky B Trommer K Viola B Wals C Zhang C Finch G Krafft W Klein Diffusible, nonfibrillary ligands derived from Aβ1–42 are potent central nervous system neurotoxins Proc Natl Acad Sci USA 95 1998 6448 6453
107. C Pike D Burdick A Walencewicz C Glabe C Cotman Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state Neuroscience 13 1993 1676 1687
108. D Cribbs C Pike S Weinstein P Velazquez C Cotman All-D-enantiomers of β-amyloid exhibit similar biological properties to all-L-β-amyloids J Biol Chem 272 1997 7431 7436
109. P Seubert C Vigo-Pelfrey F Esch M Lee H Dovey D Davis S Sinha M Schlossmacher J Whaley C Swindlehurdt R McCormack R Wolfert D Selkoe I Lieberburg D Schenk Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids Nature 359 1992 325 327
110. C Vigo-Pelfrey D Lee P Keim I Lieberburg D Schenk Characterization of β-amyloid peptide from human cerebrospinal fluid J Neurochem 61 1993 1965 1968
111. C Iadecola F Zhang K Niwa C Eckman S Turner E Fischer S Younkin D Borchelt K Hsiao G Carlson SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein Nat Neurosci 2 1999 157 161
112. G Carlson D Borchelt A Dake S Turner V Danielson J Coffin C Eckman J Meiners S Nilsen S Younkin K Hsiao Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice Hum Mol Genet 6 1997 1951 1959
113. K Bales T Verina R Dodel Y Du L Altstiel M Bender P Hyslop E Johnstone S Little D Cummins P Piccardo B Ghetti SM Paul Lack of apolipoprotein E dramatically reduces Aβ deposition Nat Genet 17 1997 254 256
114. R Schreck P Rieber P Baeuerle Reactive oxygen intermediates as apparently widely used messengers in the action of the NF-kB transcription factor and HIV-1 EMBO J 10 1991 2247 2258
115. L Futterman L Lemberg The use of antioxidants in retarding atherosclerosis: fact or fiction? Am J Crit Care 8 1999 130 133
116. J Heinecke Is lipid peroxidation relevant to atherogenesis? J Clin Invest 104 1999 135 136
117. P Witting K Pettersoon A-M Ostlund-Lindquist C Westerlund M Wagberg R Stocker Dissociation of atherogenesis from aortic accumulation of lipid hydroperoxides in Watanabe heritable hyperlipidemic rabbits J Clin Invest 104 1999 213 220
118. D Schenk R Barbour W Dunn G Gordon H Grajeda T Guido K Hu J Huang K Johnson-Wood K Khan D Kholodenko M Lee Z Liao I Lieberburg R Motter L Mutter F Soriano G Shopp N Vasquez C Vandevert S Walker M Wogulis T Ydnock D Games P Seubert Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177